NCT03015948View on ClinicalTrials.gov

A Single Dose Study of SHR4640 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 22, 2016

Primary Completion Date

November 23, 2016

Study Completion Date

November 23, 2016

Conditions
Gout
Interventions
DRUG

SHR4640

a single dose of SHR4640 (n=8) for each dose cohort

DRUG

Placebo

a single dose of placebo (n=2) for each dose cohort .

Trial Locations (1)

2000

Atridia Pty Limited, Sydney

All Listed Sponsors
lead

Atridia Pty Ltd.

INDUSTRY

NCT03015948 - A Single Dose Study of SHR4640 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter